Literature DB >> 10868835

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

S C Elbein1, K Wegner, S E Kahn.   

Abstract

OBJECTIVE: Both obesity and a family history of diabetes reduce insulin sensitivity, but the impact of obesity on insulin secretion among individuals predisposed to diabetes is uncertain. We used a pedigree-based approach to test the hypothesis that beta-cell compensation to the insulin resistance associated with obesity is defective among individuals predisposed to diabetes by virtue of a strong family history of type 2 diabetes before the development of diabetes or glucose intolerance. RESEARCH DESIGN AND METHODS: A total of 126 members of 26 families ascertained for at least a sib pair with type 2 diabetes with onset before age 65 years underwent a tolbutamide-modified frequently sampled intravenous glucose tolerance test (FSIGT). Family members included 26 individuals with impaired glucose tolerance and 100 individuals with normal glucose tolerance (NGT). The acute insulin response to glucose (AIRglucose) was determined and insulin sensitivity (S(I)) estimated by minimal model analysis of FSIGT data. The beta-cell compensation for insulin sensitivity was estimated from the disposition index (DI), calculated as the product of S(I) and AIRglucose. Obesity was measured by BMI.
RESULTS: Among all individuals, BMI was a significant predictor of both S(I) and AIRglucose, as expected. However, BMI also significantly predicted DI (P = 0.002) after correcting for age, sex, family membership, and glucose tolerance status. The relationship of BMI and DI was confirmed in 85 individuals with NGT who were aged <45 (P = 0.002) but not in 91 unrelated control individuals without a family history of diabetes. When normoglycemic individuals aged <45 were separated into three classes by BMI (< or =27, 27-30, >30), S(I) decreased progressively and significantly with obesity whereas AIRglucose rose significantly from lean to most obese classes. In contrast to the expectation of complete beta-cell compensation with obesity D1 fell significantly (P = 0.004) among obese family members. This relationship was not observed in control subjects.
CONCLUSIONS: Individuals with a genetic predisposition to diabetes show a reduced beta-cell compensatory response to the reduced insulin sensitivity associated with obesity. We propose that this impaired compensation may be one manifestation of the underlying genetic defect in susceptible individuals. This finding helps explain the multiplicative effects of family history and obesity on risk of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868835     DOI: 10.2337/diacare.23.2.221

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

Review 2.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

Authors:  Susumu Seino; Tadao Shibasaki; Kohtaro Minami
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

3.  Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus.

Authors:  Bo Zhu; Zhixin Ma; Yuning Zhu; Lei Fang; Hong Zhang; Hongwei Kong; Dajing Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-03-15       Impact factor: 3.066

4.  Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth.

Authors:  Louise A Kelly; Christianne J Lane; Marc J Weigensberg; Claudia M Toledo-Corral; Michael I Goran
Journal:  J Pediatr       Date:  2011-03       Impact factor: 4.406

Review 5.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

6.  Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

Authors:  Tamara S Hannon; M S Kirkman; Yash R Patel; Robert V Considine; Kieren J Mather
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

7.  A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study.

Authors:  C I M Panhuysen; L A Cupples; P W F Wilson; A G Herbert; R H Myers; J B Meigs
Journal:  Diabetologia       Date:  2003-03-21       Impact factor: 10.122

Review 8.  Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.

Authors:  Jeanne H Steppel; Edward S Horton
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

9.  Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus.

Authors:  Camille E Powe; Catherine Allard; Marie-Claude Battista; Myriam Doyon; Luigi Bouchard; Jeffrey L Ecker; Patrice Perron; Jose C Florez; Ravi Thadhani; Marie-France Hivert
Journal:  Diabetes Care       Date:  2016-05-13       Impact factor: 19.112

Review 10.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.